Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers
San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...
Oncology Nurse Advisor20h
HSCT From Deceased Donors: A New Frontier?
A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...
Opinion: A donor 5,000 miles away saved my life. You can save someone, too.
Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...
Syndax’s revumenib meets primary results in AML trial
Syndax (SNDX) announced positive topline results from the relapsed or refractory mutant NPM1 – mNPM1 – acute myeloid leukemia ...
The Pharma Letter15h
Syndax shares slide despite pivotal trial success
The study is testing the drug in certain patients with relapsed or refractory acute myeloid leukemia (AML ... with nearly one ...
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer
On Tuesday, Syndax Pharmaceuticals Inc (NASDAQ:SNDX) revealed topline results from the relapsed or refractory (R/R) mutant ...
Medical Xpress22h
Treatment target for aggressive leukemia discovered by disrupting its genome organization
Researchers have identified a key weakness in acute myeloid leukemia ... Experiments in cell cultures, conducted by the ...
IN8bio, Inc: IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a future ...
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.